Vascular Quality Initiative - Carotid Artery Stent. Last Name First Name Middle Initial



Similar documents
Perioperative Cardiac Evaluation

Stroke: Major Public Health Burden. Stroke: Major Public Health Burden. Stroke: Major Public Health Burden 5/21/2012

Corporate Medical Policy

Colonoscopy Data Collection Form

The Bioresorbable Vascular Stent Dr Albert Ko

Main Effect of Screening for Coronary Artery Disease Using CT

CARDIA 288 MONTH FOLLOW-UP SUPPLEMENTAL FORM (FORM B) HOSPITALIZATION CASE #: INTERVIEWER ID FY288BIVID2. Page 1 of 6 FY288BH4CN

06 Validation of risk prediction model

Cardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD

FFR CT : Clinical studies

Coronary Heart Disease (CHD) Brief

Endovascular Repair of an Axillary Artery Aneurysm: A Novel Approach

CHAPTER 9 DISEASES OF THE CIRCULATORY SYSTEM (I00-I99)

Acute Coronary Syndrome. What Every Healthcare Professional Needs To Know

Total Males Females (0.4) (1.6) Didn't believe entitled or eligible 13.0 (0.3) Did not know how to apply for benefits 3.4 (0.

NAME OF THE HOSPITAL: 1. Coronary Balloon Angioplasty: M7F1.1/ Angioplasty with Stent(PTCA with Stent): M7F1.3

Copenhagen University Hospital Rigshospitalet Aarhus University Hospital Skejby Denmark

Rural Health Information Technology Cooperative. Clinician Survey on Quality Improvement, Best Practice Guidelines, and Information Technology

Is it really so? : Varying Presentations for ACS among Elderly, Women and Diabetics. Yen Tibayan, M.D. Division of Cardiovascular Medicine

Cilostazol versus Clopidogrel after Coronary Stenting

URN: Family name: Given name(s): Address:

HA Territory-wide PCI Audit

4/7/2015. Cardiac Rehabilitation: From the other side of the glass door. Chicago, circa Objectives. No disclosures, no conflicts

Internal Carotid Artery Stenting in Patients over 80 Years of Age: Single-Center Experience and Review of the Literature

Perioperative Risk Stratification for Noncardiac Surgical Patients with Cardiac Diagnosis. Michael A. Blazing

Renovascular Hypertension

SOUTH EAST WALES CARDIAC NETWORK INTEGRATED CARE PATHWAY CARDIAC REHABILITATION MAY 2005

2/20/2015. Cardiac Evaluation of Potential Solid Organ Transplant Recipients. Issues Specific to Transplantation. Kidney Transplantation.

Ostial LAD: Single stent approach is the best. Antonio A. Pocoví, MD, FSCAI, MTSAC, Advisory Council Member, CACI

Treating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC

Level III Stroke Center Data Collection Requirements

Antonio Colombo MD on behalf of the SECURITY Investigators

Wingspan Stent System with Gateway PTA Balloon Catheter

Estimated Population Responding on Item 25,196,036 2,288,572 3,030,297 5,415,134 4,945,979 5,256,419 4,116,133 Medicare 39.3 (0.2)

ACTION Registry GWTG Version 2.4

Ultrasound in Vascular Surgery. Torbjørn Dahl

Demographics. MBSAQIP Case Number: IDN: ACS NSQIP Case Number:

AnMed Health Disparities Dashboard

Physician and other health professional services

Steven J. Yakubov, MD FACC For the CoreValve US Clinical Investigators

Secondary Stroke Prevention Luke Bradbury, MD 10/4/14 Fall WAPA Conferfence

Understanding Coronary Artery Disease, Cardiac Catheterization, and Treatment Options. A Guide for Patients

Q1: Global risk assessment using PROCAM, SCORE, FRAMINGHAM or REYNOLDS ecc is sufficient YES NO NEED MORE DATA DISCUSS within Taskforce Your Comments

Medical Management of Ischemic Stroke: An Update. Siddharth Sehgal, MD Medical Director, TMH Neuroscience Center

Objectives. Preoperative Cardiac Risk Stratification for Noncardiac Surgery. History

Cardiovascular diseases. pathology

Physician address. Physician phone

Risk Adjustment Factor (RAF) RADV June 1 st 2016

RISK STRATIFICATION for Acute Coronary Syndrome in the Emergency Department

PATIENT INFORMATION INTAKE F O R M BESSMER CHIROPRACTIC P. C.

Is Stenting or Coronary Artery By-pass Grafting the Better Treatment for This Patient?

SOUTH PALM CARDIOVASCULAR ASSOCIATES, INC. CHARLES L. HARRING, M.D. NEW PATIENT INFORMATION FORM. Patient Name: Home Address:

INTRODUCTION TO EECP THERAPY

6/5/2014. Objectives. Acute Coronary Syndromes. Epidemiology. Epidemiology. Epidemiology and Health Care Impact Pathophysiology

Thoracoabdominal aortic aneurysm

Presenter: Marco Valgimigli, MD PhD, FESC Erasmus MC, Thoraxcenter Rotterdam The Netherlands

Majestic Trial 12 Month Results

Vertebrobasilar Disease

Pre-Operative Cardiac Evaluation Kalpana Jain, MD

Antiplatelet and anticoagulation treatment of patients undergoing carotid and peripheral artery angioplasty

Strategic Implementation and Automation of an Administrative Database into Practice while Minimizing Human- Resources

There are 5 demographic data elements that include gender, date of birth, race, ethnicity status,

Patient Registration Form

BOARD MEETING: March 27-28, Silver Cross Hospital and Medical Center, Joliet STATE AGENCY REPORT

Efficient Evaluation of Chest Pain

High Risk Emergency Medicine

2013 ACO Quality Measures

REPORTING STENT PLACEMENT FOR NONOCCLUSIVE VASCULAR DISEASE IN LOWER EXTREMITIES

Listen to your heart: Good Cardiovascular Health for Life

CLINICAL QUALITY MEASURES FINALIZED FOR ELIGIBLE HOSPITALS AND CRITICAL ACCESS HOSPITALS BEGINNING WITH FY 2014

PRECOMBAT Trial. Seung-Whan Lee, MD, PhD On behalf of the PRECOMBAT Investigators

PATIENT INFORMATION - Please complete and/or verify all information and make changes as necessary.

AVAILABILITY AND ACCESSIBILITY OF CARDIAC REHABILITATION SERVICES IN LOW- AND MIDDLE-INCOME COUNTRIES QUESTIONNAIRE

Mar. 31, 2011 (202) Improving Quality of Care for Medicare Patients: Accountable Care Organizations

Age # % State Avg % 16% % 24% % 19% % 23% % 14% % 4% Ethnicity # % State Avg

CARDIAC CARE. Giving you every advantage

Making the Case for CPG s Jean Luciano, MSN, RN, CNRN, SCRN, CRNP, FAHA Claranne Mathiesen, MSN, RN, CNRN, SCRN, FAHA

Management of the Patient with Aortic Stenosis undergoing Non-cardiac Surgery

For the NXT Investigators

PHYSICIAN ORDERS TRANSIENT ISCHEMIC ATTACK (TIA) OBSERVATION

Performance Measurement for the Medicare and Medicaid Eligible (MME) Population in Connecticut Survey Analysis

Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease

3/2/2010 Post CABG R h e bili a i tat on Ahmed Elkerdany Professor o f oof C ardiac Cardiac Surgery Ain Shams University 1

FULL COVERAGE FOR PREVENTIVE MEDICATIONS AFTER MYOCARDIAL INFARCTION IMPACT ON RACIAL AND ETHNIC DISPARITIES

Stroke Prevention in Primary Care

Bryant T. Aldridge Rehabilitation Center Unit Specific Inclusive Diversity Analysis: CULTURAL COMPETENCY AND DIVERSITY PLAN February 2015

Treatment of diabetes In order to survive, people with type 1 diabetes must have insulin delivered by a pump or injections.

Complete coverage. Unbeatable value.

Is this pt s brain dysfunction due to ischemia? Onset & progression of sx; location of deficit

Your appointment is scheduled for at with Dr. Your arrival time is.

Pre-Screening and Risk Stratification

TALLAHASSEE EYE CENTER

Overview. Total Joint Replacement in the U.S. KP National Total Joint Registry EMR Tools and Outcome Assessment: A Model for Vascular Surgery?

Ischemic Heart Disease: Angina Pectoris

Transportation Construction Apprenticeship Readiness Training T.C.A.R.T. Cell Phone Date of Birth (mm/dd/yyyy) Gender: Male

In hospital diabetes care background and challenges. Duality of interest. One of the goals may be...

Provider Checklist-Outpatient Imaging. Checklist: Nuclear Stress Test, Thallium/Technetium/Sestamibi (CPT Code )

PROTEGE. Carotid Stent System INSTRUCTIONS FOR USE. CAUTION: Federal (U.S.A.) law restricts this device to sale by or on the order of a physician.

ANESTHESIA FOR PATIENTS WITH CORONARY STENTS FOR NON CARDIAC SURGERY. Dr. Mahesh Vakamudi. Professor and Head

Transcription:

Vascular Quality Initiative - Carotid Artery Stent Last Name First Name Middle Initial Date of Birth Medical Record Social Security General Information Patient Data Zip/Postal Code Gender Male Female Ethnicity Not Hispanic or Latino Hispanic or Race White Black or African American Height inches or cm Latino Asian More than 1 race American Indian or Alaskan Native Weight lbs or kg Native Hawaiian or other Pacific Islander /other Admission Data Visit code (not required) Admit Date Discharge Date Primary Physician Surgery Date Did Primary Physician bill to Medicare Part B? No Yes Assistant Medicare Health Insurance Claim Discharge Status Home Rehab Unit Nursing Home Dead Other Hospital Skilled Nursing Facility If dead, date of death Transferred from? No Hospital Rehab Unit Demographics Smoking Never Prior (>1 yr) Hypertension No Yes (>=140/90 or history) Current (within 1 yr) Diabetes None Diet Oral Meds Beta Blockers No Op Day only Insulin Pre-op 1-30 days Chronic > 30 days Intolerant CAD None hx MI but no sx CABG/ None <5yr >=5yrs ago Symptoms Stable Angina Unstable PTCA Angina or MI < 6 mos CHF None Asymp, hx CHF COPD No Not Treated On Meds Mild Severe On Home Oxygen Dialysis No Functioning Transplant Creatinine mg/dl OR umol/l On Dialysis Stress Test Not Done Normal Pre-adm Living Home Nursing Home (+)ischemia (+)MI (+)both

ASA 1=Normal/healthy 2=w/Mild Systemic dx Pre-op Hemoglobin g/dl OR g/l Class 3=w/Severe Systemic dx 4=w/Severe Systemic dx That's Constant Threat to Life 5=Moribund/not Expected to Survive w/o Op Previous Arterial Bypass No Yes CEA No Yes Aneurysm Repair No Yes PTA/Stent No Yes Major Amp No Yes Pre-Op Medications ASA No Yes Intolerant Plavix No Yes Intolerant Statin No Yes Intolerant History Symptoms: Ocular Ipsilat Asymptomatic Ocular Contralat Asymptomatic Cortical Ipsilat Asymptomatic Cortical Contralat Asymptomatic If Ocular Ipsilat, Ocular Contralat, Cortical Ipsilat or Cortical Contralat equals minor or major stroke: Rankin Score 0 1 2 3 4 5 Vertebrobasilar Asymptomatic Non-Specific No Yes Previous Ipsilat CEA No Yes Previous Contralat CEA No Yes Previous Ipsilat Carotid Stent No Yes Ipsilat Stroke on CT/MRI? No Yes Medical High Anatomic Not done Risk No Yes High Risk No Yes Refused for Surgery No Yes Pre-op: Duplex No Yes MRA No Yes CTA No Yes Arteriogram No Yes

ICA Stenosis: Ipsilateral <50% >50% Contralateral <50% >50% >60% >70% >60% >70% >80% Occluded >80% Occluded Procedure Urgency Elective Site IR Anesthesia Local General Urgent Cardiac Cath Emergent OR, fixed OR, mobile Side Right Left Lesion Atherosclerosis Lesion Length mm Type Re-Stenosis Dissection Trauma Other Stenosis by % Second Stenosis No Yes If yes, Second Angiography Stenosis Severity % Upper Extent C1 C2 Approach Femoral Prophylactic Antibradyarrhythmic No Yes of Lesion C3 C4 Trans-Carotid (Location) C5 C6 Brachial Heparin No Yes Protamine No Yes Contrast Volume ml Bradyarrhythmia No Yes Protection No Yes Requiring Tx Device Failure Neurologic No Yes If Neurologic Change is Decreased LOC Seizure Change Yes, Neuro Change Type Stroke Other Lesion(s) Treated CCA Only Bifurcation or ICA Only CCA + Bifurcation or ICA Heart Rate: On Arrival in OR bpm Highest intra-op bpm Common Carotid Artery Pre-dilate Before Protection Device No Yes Protection Device None Angioguard Accunet Filterwire Percusurge Retrograde Flow Neuroshield Other Emboshield Spider Technical Failure No Yes If Technical Failure is Yes, Cause of Failure Can't Canulate CCA + Sheath Can't cross lesion Other If Technical Failure is No: Pre-dilate Before Stent No Yes Stent Type Wall Precise Acculink Other Xact Nexstent Vivexx Stent Diameter mm Tapered No Yes Stent Length mm of Stents Post Dilate No Yes Balloon Diameter mm (largest size used during procedure)

Bifurcation or ICA Pre-dilate Before Protection Device No Yes Protection Device None Angioguard Accunet Filterwire Percusurge Retrograde Flow Neuroshield Other Emboshield Spider Technical Failure No Yes If Technical Failure is Yes, Cause of Failure Can't Canulate CCA + Sheath Can't cross lesion Other If Technical Failure is No: Pre-dilate Before Stent No Yes Stent Type Wall Precise Acculink Other Xact Nexstent Vivexx Stent Diameter mm Tapered No Yes Stent Length mm of Stents Post Dilate No Yes Balloon Diameter mm (largest size used during procedure) Post-Op Data Ipsilat Neurological Event No Time of Onset Intra-op < 6 hrs post-op >= 6 hrs post-op Contralat Neurologic Event No Time of Onset Intra-op < 6 hrs post-op >= 6 hrs post-op 2b3a Inhibitor Post-op No Yes Reperfusion Symptoms None Seizure or Hemorrhage Myocardial Infarction No Troponin Only Dysrhythmia (new) No Yes EKG or Clinical CHF No Yes Access Site Cx No Minimal Hematoma/PA Hematoma/PA Req. Transfusion Required Operation IV Med Required For: Arterial Occlusion Hypertension No Yes Hypotension No Yes Discharge Medications: ASA No Yes Intolerant Plavix No Yes Intolerant Statin No Yes Intolerant Beta-Blocker No Yes Intolerant Other Antiplatelet No Yes Intolerant v1.12

Vascular Quality Initiative - Carotid Artery Stent Follow-Up Last Name First Name Middle Initial Date of Birth Medical Record Social Security Visit code (not required) Zip/Postal Code Physician Procedure: Carotid Artery Stent Surgery Date Side: General Information Date of Contact Contact By Face to Face Current Smoking No Phone Yes No Follow-up Possible Current Living Status Home Date of Death Cause Operation Related Nursing Home Non-Related Dead Unsure Current Medications ASA No Plavix No Coumadin No Beta Blocker No Statin No Yes Yes Yes Yes Yes Intolerant Intolerant Intolerant Intolerant Intolerant Carotid Artery Stent Ipsilat Neurological Event No Date of Event: Contralat Neurologic Event No Date of Event: Duplex CEA Site <50% >50% >60% >70% >80% Occluded Not Done CAS Site Re-intervention No Yes If Yes, Date of PTA/Stent: CAS Site Endarterectomy No Yes If Yes, Date of Procedure: v1.12